Viewing StudyNCT00255346



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00255346
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2005-11-16

Brief Title: Dasatinib as Therapy for Myeloproliferative Disorders MPDs
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-11-15
Start Date Type: ACTUAL
Primary Completion Date: 2017-03-03
Primary Completion Date Type: ACTUAL
Completion Date: 2017-03-03
Completion Date Type: ACTUAL
First Submit Date: 2005-11-16
First Submit QC Date: November 16 2005
Study First Post Date: 2005-11-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2019-05-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-13
Last Update Post Date: 2023-12-18
Last Update Post Date Type: ACTUAL